During the trial, to whom should the investigator provide documents subject to review?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

During the trial, to whom should the investigator provide documents subject to review?

Explanation:
In GCP, the IRB/IEC is the body responsible for ethical review and ongoing oversight of the trial to protect participants’ rights and welfare. Because of that role, investigators must provide documents that are subject to review to the IRB/IEC so they can assess safety, consent processes, and compliance with the protocol. This includes things like the protocol, informed consent forms, consent/assent documents, any amendments, continuing review reports, and safety or adverse event summaries as requested. While sponsors may need access to certain trial documents for monitoring and regulatory submissions, and regulatory authorities may inspect records, the primary recipient for documents that require formal review is the IRB/IEC. Trial participants receive information through approved consent materials and ongoing communications, not the full set of study documents.

In GCP, the IRB/IEC is the body responsible for ethical review and ongoing oversight of the trial to protect participants’ rights and welfare. Because of that role, investigators must provide documents that are subject to review to the IRB/IEC so they can assess safety, consent processes, and compliance with the protocol. This includes things like the protocol, informed consent forms, consent/assent documents, any amendments, continuing review reports, and safety or adverse event summaries as requested.

While sponsors may need access to certain trial documents for monitoring and regulatory submissions, and regulatory authorities may inspect records, the primary recipient for documents that require formal review is the IRB/IEC. Trial participants receive information through approved consent materials and ongoing communications, not the full set of study documents.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy